Tackling the excesses of pharmaceutical marketing and promotion

Ravi Gupta and colleagues argue that we need to reconsider standards for targeted pharmaceutical marketing to doctors through speaker programmes, consulting programmes, and advisory board positions

Saved in:
Bibliographic Details
Published inBMJ (Online) Vol. 385; p. e076797
Main Authors Gupta, Ravi, Ramachandran, Reshma, Ross, Joseph S
Format Journal Article
LanguageEnglish
Published England British Medical Journal Publishing Group 21.05.2024
BMJ Publishing Group LTD
Subjects
Advertising
Analysis
Consultants
Direct marketing
Drug Industry
Humans
Kickbacks
Litigation
Marketing
Meals
Multiple sclerosis
Narcotics
Pharmaceutical industry
Physicians
Prescription drugs
R&D
Research & development
Settlements & damages
United Kingdom
United Kingdom
United States > US
Online AccessGet full text

Cover

More Information
Summary:Ravi Gupta and colleagues argue that we need to reconsider standards for targeted pharmaceutical marketing to doctors through speaker programmes, consulting programmes, and advisory board positions
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Editorial-2
ObjectType-Commentary-1
ObjectType-Article-3
ISSN:1756-1833
1756-1833
DOI:10.1136/bmj-2023-076797